SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants
SARS-COV-2 중화 항체 : 신흥 바이러스 변이체에 의한 장수, 폭 및 회피
Research Article
[키워드] acute respiratory syndrome
Antibody neutralization
breadth
Breakthrough infection
Chain Reaction
characterized
convalescent plasma
coronavirus
coronavirus 2
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 severity
Critical
demographics
donors
high responders
immunoreactivity
individual
Longevity
membrane
neutralization potency
Neutralizing
neutralizing response
Nucleocapsid proteins
polymerase chain
polymerase chain reaction
Proteins
reduced
Reinfection
representing
respiratory
Responder
reverse transcription
reverse transcription polymerase chain reaction
risk
RT-PCR
SARS-CoV-2
SARS-CoV-2 antibody response
SARS-CoV-2 antibody responses
SARS-CoV-2 antigen
SARS-CoV-2 antigens
SARS-CoV-2 neutralization
SARS-CoV-2 spike
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severity
spike
spike variants
sustained
vaccination
Vaccine
variant
variants
Viral
viral neutralization
viral variant
Viral variants
VoC
with COVID-19
[DOI] 10.1371/journal.pmed.1003656 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pmed.1003656 PMC 바로가기 [Article Type] Research Article